A Methodology Study Of Brain Imaging Of Pain-Killers In Post-Traumatic Neuropathic Pain Patients
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study is a methodology study designed to discover whether a brain imaging technology is
a better way of compare the relative sensitivities of fMRI and subjective psychometric
assessments of pain to multiple doses of pregabalin and tramadol SR in a cross-over clinical
study design.
Phase:
N/A
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.